NCT07415746Not yet recruiting
Functional Assessment and Pulmonary Rehabilitation: Challenges and Perspectives for Comprehensive Care
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
Individuals with Chronic Obstructive Pulmonary Disease (COPD) present with respiratory muscle dysfunction, characterized by reduced diaphragmatic contractility and mobility due to pulmonary hyperinflation, oxidative stress, and systemic inflammation. Effective assessment of diaphragmatic function is crucial for monitoring progress in pulmonary rehabilitation programs. This study aims to evaluate diaphragmatic function and mobility in COPD patients undergoing pulmonary rehabilitation with inspiratory muscle training, using ultrasound, and to identify associations between diaphragmatic dysfunction and clinical symptoms such as dyspnea and fatigue. A randomized clinical trial will be conducted to investigate the impact of rehabilitation on diaphragmatic function, correlating it with pulmonary function and physical performance.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- First submitted
- 23 Jan 2026
- Start date
- Mar 2026
- Primary completion date
- Oct 2026
- Lead sponsor
- Universidade do Estado do Pará
- Diseases
- COPD
- NCT number
- NCT07415746
What you commit to
- Study type: Interventional
- Planned participants: 46
- From Mar 2026 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently engaged in physical therapy treatment and/or physical activity that may interfere with the study results.
Other illness
- Physical limitations and/or cognitive impairment that prevent the execution of the study protocol.
Other
- Presence of severe, uncontrolled, or disabling comorbidities.
Who the study is looking for
- Age 40 years or older.
- Both sexes are eligible (men and women).
- Clinically diagnosed COPD, clinically stable, classified in Stages I, II, III or IV of GOLD (Global Initiative for Chronic Obstructive Lung Disease).
- Ability to understand and provide the signed Informed Consent Form to participate in the study.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Teaching and Assistance Unit in Physiotherapy and Occupational Therapy Coordinator of this site? Confirm its status | Belém | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.